Literature DB >> 26644228

Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women.

Juçara Maria de Castro-Sobrinho1, Silvia Helena Rabelo-Santos2, Rosane Ribeiro Fugueiredo-Alves3, Sophie Derchain4, Luis Otávio Z Sarian4, Denise R Pitta4, Elisabete A Campos4, Luiz Carlos Zeferino4.   

Abstract

Vaginal infections may affect susceptibility to and clearance of human papillomavirus (HPV) infection and chronic inflammation has been linked to carcinogenesis. This study aimed to evaluate the association between bacterial vaginosis (BV) and inflammatory response (IR) with the severity of cervical neoplasia in HPV-infected women. HPV DNA was amplified using PGMY09/11 primers and genotyping was performed using a reverse line blot hybridization assay in 211 cervical samples from women submitted to excision of the transformation zone. The bacterial flora was assessed in Papanicolaou stained smears, and positivity for BV was defined as ≥ 20% of clue cells. Present inflammatory response was defined as ≥ 30 neutrophils per field at 1000× magnification. Age higher than 29 years (OR:1.91 95% CI 1.06-3.45), infections by the types 16 and/or 18 (OR:1.92 95% CI 1.06-3.47), single or multiple infections associated with types 16 and/or 18 (OR: 1.92 CI 95% 1.06-3.47), BV (OR: 3.54 95% CI 1.62-7.73) and IR (OR: 6.33 95% CI 3.06-13.07) were associated with severity of cervical neoplasia (CIN 2 or worse diagnoses), while not smoking showed a protective effect (OR: 0.51 95% CI 0.26-0.98). After controlling for confounding factors, BV(OR: 3.90 95% CI 1.64-9.29) and IR (OR: 6.43 95% CI 2.92-14.15) maintained their association with the severity of cervical neoplasia. Bacterial vaginosis and inflammatory response were independently associated with severity of cervical neoplasia in HPV-positive women, which seems to suggest that the microenvironment would relate to the natural history of cervical neoplasia.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  bacterial vaginosis; cervical cancer; cervical smears; human papillomavirus; inflammatory response

Mesh:

Year:  2015        PMID: 26644228     DOI: 10.1002/dc.23388

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  11 in total

1.  Gardnerella vaginalis and Prevotella bivia Trigger Distinct and Overlapping Phenotypes in a Mouse Model of Bacterial Vaginosis.

Authors:  Nicole M Gilbert; Warren G Lewis; Guocai Li; Dorothy K Sojka; Jean Bernard Lubin; Amanda L Lewis
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

2.  A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women.

Authors:  Xiaolin Xu; Yichan Zhang; Liqun Yu; Xingxian Shi; Min Min; Lijuan Xiong; Jia Pan; Peipei Liu; Guizhen Wu; Guolan Gao
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

3.  CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway.

Authors:  Aiqin He; Jia Shao; Yu Zhang; Hong Lu; Zhijun Wu; Yunzhao Xu
Journal:  Oncotarget       Date:  2017-05-16

Review 4.  Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs.

Authors:  Sarah Gupta; Christina Palmer; Elisabeth M Bik; Juan P Cardenas; Harold Nuñez; Laurens Kraal; Sara W Bird; Jennie Bowers; Alison Smith; Nathaniel A Walton; Audrey D Goddard; Daniel E Almonacid; Susan Zneimer; Jessica Richman; Zachary S Apte
Journal:  Front Public Health       Date:  2018-04-09

5.  Multiple sexual partners and vaginal microecological disorder are associated with HPV infection and cervical carcinoma development.

Authors:  Yu Huang; Xinzhi Wu; Ying Lin; Wenzhou Li; Jiahua Liu; Baozhi Song
Journal:  Oncol Lett       Date:  2020-06-16       Impact factor: 2.967

Review 6.  NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer.

Authors:  Fernando J Velloso; Marina Trombetta-Lima; Valesca Anschau; Mari C Sogayar; Ricardo G Correa
Journal:  Biosci Rep       Date:  2019-04-09       Impact factor: 3.840

Review 7.  MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies.

Authors:  Gulcin Tezcan; Ekaterina V Martynova; Zarema E Gilazieva; Alan McIntyre; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Front Pharmacol       Date:  2019-05-01       Impact factor: 5.810

8.  Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study.

Authors:  Johanna Wiik; Verena Sengpiel; Maria Kyrgiou; Staffan Nilsson; Anita Mitra; Tom Tanbo; Christine Monceyron Jonassen; Tone Møller Tannæs; Katrine Sjøborg
Journal:  BMC Womens Health       Date:  2019-02-06       Impact factor: 2.809

Review 9.  Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.

Authors:  Sonia Missiroli; Mariasole Perrone; Caterina Boncompagni; Chiara Borghi; Alberto Campagnaro; Francesco Marchetti; Gabriele Anania; Pantaleo Greco; Francesco Fiorica; Paolo Pinton; Carlotta Giorgi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

Review 10.  Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Authors:  Giovanni Barillari; Roberto Bei; Vittorio Manzari; Andrea Modesti
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.